Association Between Systemic Immune Inflammation Level and Poor Prognosis Across Different Glucose Metabolism Status in Coronary Artery Disease Patients

References

• Roth GA, Forouzanfar MH, Moran AE, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372(14):1333–1341. doi:10.1056/NEJMoa1406656
   PubMed Web of Science ®Google Scholar
• Collaborators GCoD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788. doi:10.1016/S0140-6736(18)32203-7
   PubMed Web of Science ®Google Scholar
• Collaborators GDaIIaP. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259. doi:10.1016/S0140-6736(17)32154-2
   Web of Science ®Google Scholar
• Ding D, Qiu J, Li X, et al. Hyperglycemia and mortality among patients with coronary artery disease. Diabetes Care. 2014;37(2):546–554. doi:10.2337/dc13-1387
   Web of Science ®Google Scholar
• Sarwar N, Gao P; Emerging Risk Factors C. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–2222. doi:10.1016/S0140-6736(10)60484-9
   PubMed Web of Science ®Google Scholar
• Cai X, Zhang Y, Li M, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370:m2297. doi:10.1136/bmj.m2297
   PubMed Web of Science ®Google Scholar
• Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ. 2016;355:i5953. doi:10.1136/bmj.i5953
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Professional Practice C. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–S38. doi:10.2337/dc22-S002
   PubMedGoogle Scholar
• Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020;41(2):255–323. doi:10.1093/eurheartj/ehz486
   PubMed Web of Science ®Google Scholar
• Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2022;65(12):1925–1966. doi:10.1007/s00125-022-05787-2
   PubMed Web of Science ®Google Scholar
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352(16):1685–1695. doi:10.1056/NEJMra043430
   PubMed Web of Science ®Google Scholar
• Fioranelli M, Bottaccioli AG, Bottaccioli F, Bianchi M, Rovesti M, Roccia MG. Stress and inflammation in coronary artery disease: a review psychoneuroendocrineimmunology-based. Front Immunol. 2018;9:2031. doi:10.3389/fimmu.2018.02031
   PubMed Web of Science ®Google Scholar
• Odegaard AO, Jacobs DR Jr, Sanchez OA, Goff DC Jr, Reiner AP, Gross MD. Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes. Cardiovasc Diabetol. 2016;15(1):51. doi:10.1186/s12933-016-0369-6
   PubMedGoogle Scholar
• Liu Y, Ye T, Chen L, et al. Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease. Coron Artery Dis. 2021;32(8):715–720. doi:10.1097/MCA.0000000000001037
   PubMed Web of Science ®Google Scholar
• Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230
   PubMed Web of Science ®Google Scholar
• Candemir M, Kiziltunc E, Nurkoc S, Sahinarslan A. Relationship between systemic immune-inflammation index (SII) and the severity of stable coronary artery disease. Angiology. 2021;72(6):575–581. doi:10.1177/0003319720987743
   PubMed Web of Science ®Google Scholar
• Saylik F, Akbulut T. Systemic immune-inflammation index predicts major cardiovascular adverse events in patients with ST-segment elevated myocardial infarction. Arq Bras Cardiol. 2022;119(1):14–22. doi:10.36660/abc.20210412
   PubMed Web of Science ®Google Scholar
• Xu M, Chen R, Liu L, et al. Systemic immune-inflammation index and incident cardiovascular diseases among middle-aged and elderly Chinese adults: the Dongfeng-Tongji cohort study. Atherosclerosis. 2021;323:20–29. doi:10.1016/j.atherosclerosis.2021.02.012
   PubMed Web of Science ®Google Scholar
• Aguiar-Souto P, Ferrante G, Del Furia F, Barlis P, Khurana R, Di Mario C. Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions. Int J Cardiol. 2010;139(1):68–74. doi:10.1016/j.ijcard.2008.10.006
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461–470. doi:10.7326/0003-4819-130-6-199903160-00002
   PubMed Web of Science ®Google Scholar
• Agrawal H, Choy HK, Liu J, Auyoung M, Albert MA. Coronary artery disease. Arterioscler Thromb Vasc Biol. 2020;40(7):e185–e192. doi:10.1161/ATVBAHA.120.313608
   Web of Science ®Google Scholar
• Lai W, Xie Y, Zhao X, et al. Elevated systemic immune inflammation level increases the risk of total and cause-specific mortality among patients with chronic kidney disease: a large multi-center longitudinal study. Inflamm Res. 2023;72(1):149–158. doi:10.1007/s00011-022-01659-y
   PubMed Web of Science ®Google Scholar
• Lai W, Zhao X, Huang Z, et al. Elevation of preprocedural systemic immune inflammation level increases the risk of contrast-associated acute kidney injury following coronary angiography: a Multicenter Cohort Study. J Inflamm Res. 2022;15:2959–2969. doi:10.2147/JIR.S364915
   PubMed Web of Science ®Google Scholar
• Zhou YX, Li WC, Xia SH, et al. Predictive value of the systemic immune inflammation index for adverse outcomes in patients with acute ischemic stroke. Front Neurol. 2022;13:836595. doi:10.3389/fneur.2022.836595
   PubMed Web of Science ®Google Scholar
• Rinde LB, Småbrekke B, Hald EM, et al. Myocardial infarction and future risk of cancer in the general population-The Tromsø Study. Eur J Epidemiol. 2017;32(3):193–201. doi:10.1007/s10654-017-0231-5
   Web of Science ®Google Scholar
• Nøst TH, Alcala K, Urbarova I, et al. Systemic inflammation markers and cancer incidence in the UK Biobank. Eur J Epidemiol. 2021;36(8):841–848. doi:10.1007/s10654-021-00752-6
   PubMed Web of Science ®Google Scholar
• Kiorpes AL, Clayton MK. Moment analysis of multibreath nitrogen washout in healthy female goats and calves. Am J Vet Res. 1988;49(4):543–547.
   Web of Science ®Google Scholar
• Li J, Cao D, Huang Y, et al. The prognostic and clinicopathological significance of systemic immune-inflammation index in bladder cancer. Front Immunol. 2022;13:865643. doi:10.3389/fimmu.2022.865643
   PubMed Web of Science ®Google Scholar
• May AE, Langer H, Seizer P, Bigalke B, Lindemann S, Gawaz M. Platelet-leukocyte interactions in inflammation and atherothrombosis. Semin Thromb Hemost. 2007;33(2):123–127. doi:10.1055/s-2007-969023
   PubMed Web of Science ®Google Scholar
• Shah AD, Denaxas S, Nicholas O, Hingorani AD, Hemingway H. Neutrophil counts and initial presentation of 12 cardiovascular diseases: a CALIBER Cohort Study. J Am Coll Cardiol. 2017;69(9):1160–1169. doi:10.1016/j.jacc.2016.12.022
   PubMed Web of Science ®Google Scholar
• Naito R, Miyauchi K. Coronary artery disease and type 2 diabetes mellitus. Int Heart J. 2017;58(4):475–480. doi:10.1536/ihj.17-191
   PubMed Web of Science ®Google Scholar
• Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Curr Diab Rep. 2013;13(3):435–444. doi:10.1007/s11892-013-0375-y
   PubMed Web of Science ®Google Scholar
• Prasad M, Chen EW, Toh SA, Gascoigne NRJ. Autoimmune responses and inflammation in type 2 diabetes. J Leukoc Biol. 2020;107(5):739–748. doi:10.1002/JLB.3MR0220-243R
   Web of Science ®Google Scholar
• King GL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008;79(8 Suppl):1527–1534. doi:10.1902/jop.2008.080246
   PubMed Web of Science ®Google Scholar
• Calle MC, Fernandez ML. Inflammation and type 2 diabetes. Diabetes Metab. 2012;38(3):183–191. doi:10.1016/j.diabet.2011.11.006
   PubMed Web of Science ®Google Scholar
• Katakami N. Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus. J Atheroscler Thromb. 2018;25(1):27–39. doi:10.5551/jat.RV17014
   PubMed Web of Science ®Google Scholar
• Liang Y, Wang M, Wang C, Liu Y, Naruse K, Takahashi K. The mechanisms of the development of atherosclerosis in prediabetes. Int J Mol Sci. 2021;22(8). doi:10.3390/ijms22084108
   Web of Science ®Google Scholar
• Mojiminiyi OA, Abdella N, Moussa MA, Akanji AO, Al Mohammedi H, Zaki M. Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2002;58(1):37–44. doi:10.1016/S0168-8227(02)00101-8
   Web of Science ®Google Scholar
• Soinio M, Marniemi J, Laakso M, Lehto S, Ronnemaa T. High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study. Diabetes Care. 2006;29(2):329–333. doi:10.2337/diacare.29.02.06.dc05-1700
   PubMed Web of Science ®Google Scholar
• Sabatine MS, Morrow DA, Cannon CP, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy. J Am Coll Cardiol. 2002;40(10):1761–1768.
   PubMedGoogle Scholar
• Liu SL, Wu NQ, Shi HW, et al. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease. Cardiovasc Diabetol. 2020;19(1):36. doi:10.1186/s12933-020-01012-9
   PubMed Web of Science ®Google Scholar
• Wang P, Yuan D, Zhang C, et al. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort. Cardiovasc Diabetol. 2022;21(1):46. doi:10.1186/s12933-022-01477-w
   PubMed Web of Science ®Google Scholar
• Huang X, Yang S, Zhao Q, et al. Predictive value of non-high-density lipoprotein cholesterol and neutrophil-lymphocyte ratio for coronary artery vulnerable plaques in type 2 diabetes mellitus. Front Cardiovasc Med. 2022;9:927768. doi:10.3389/fcvm.2022.927768
   PubMed Web of Science ®Google Scholar
• Mugabo Y, Li L, Renier G. The connection between C-reactive protein (CRP) and diabetic vasculopathy. Focus on preclinical findings. Curr Diabetes Rev. 2010;6(1):27–34. doi:10.2174/157339910790442628
   Google Scholar
• Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006;97(2A):3A–11A. doi:10.1016/j.amjcard.2005.11.010
   PubMed Web of Science ®Google Scholar
• He J, Bian X, Song C, et al. High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study. Cardiovasc Diabetol. 2022;21(1):156. doi:10.1186/s12933-022-01583-9
   PubMed Web of Science ®Google Scholar
• Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation. 2016;133(11):1104–1114. doi:10.1161/CIRCULATIONAHA.115.020406
   PubMed Web of Science ®Google Scholar